Detalhe da pesquisa
1.
Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
Int J Gynecol Pathol
; 43(1): 25-32, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255450
2.
Investigating the efficacy of tissue factor pathway inhibitor2 as a promising prognostic marker for ovarian cancer.
Oncol Lett
; 28(1): 302, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38774455
3.
Endogenous Microbacteria Can Contribute to Ovarian Carcinogenesis by Reducing Iron Concentration in Cysts: A Pilot Study.
Microorganisms
; 12(3)2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543589
4.
MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study.
Diagnostics (Basel)
; 14(11)2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38893596
5.
The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial.
Trials
; 25(1): 68, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243317
6.
Verification of selective and individual pulmonary thromboembolism prophylaxes for cesarean delivery.
Obstet Gynecol Sci
; 66(3): 181-189, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945725
7.
Preoperative serum tissue factor pathway inhibitor2 level as a prognostic marker for endometrial cancer.
Oncol Lett
; 26(5): 463, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854864
8.
The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer.
Sci Rep
; 12(1): 22636, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36587139
9.
The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma.
Biomedicines
; 10(11)2022 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36359203
10.
The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy.
Diagnostics (Basel)
; 12(5)2022 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626367
11.
A diagnostic challenge of seromucinous borderline tumor: A case report.
Medicine (Baltimore)
; 98(22): e15707, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31145284
12.
Magnetic resonance relaxometry improves the accuracy of conventional MRI in the diagnosis of endometriosis-associated ovarian cancer: A case report.
Mol Clin Oncol
; 11(3): 296-300, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396388